André Deschamps, of Europa Uomo, Antwerpen, Belgium, discusses the effect of prostate cancer treatment as evaluated in the EUPROMS study, the first ever patient driven quality of life (QoL) study. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).